Edition:
United Kingdom

Genetic Technologies Ltd (GENE.OQ)

GENE.OQ on NASDAQ Stock Exchange Capital Market

1.15USD
16 Nov 2018
Change (% chg)

$-0.01 (-0.86%)
Prev Close
$1.16
Open
$1.16
Day's High
$1.18
Day's Low
$1.12
Volume
2,919
Avg. Vol
63,715
52-wk High
$2.05
52-wk Low
$0.79

Chart for

About

Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment... (more)
No analyst recommendations are available for .

Overall

Beta: 2.64
Market Cap(Mil.): $15.14
Shares Outstanding(Mil.): 16.24
Dividend: --
Yield (%): --

Financials

  GENE.OQ Industry Sector
P/E (TTM): -- 83.63 33.59
EPS (TTM): -0.47 -- --
ROI: -74.37 -0.64 15.05
ROE: -74.83 0.08 16.62

Earnings vs. Estimates